??US Employment Data and Positive Developments in China Spark Optimism!

Recent US Job Openings Data at Lowest since Early 2021, Supporting Case for Fed Rate Pause; China's Market-Friendly Actions Lift Sentiment as Europe Begins Its Day. On Wednesday, Asian equity markets responded to a surge on Wall Street, driven by growing speculation that the Federal Reserve might be halting its monetary tightening measures, causing traders to revise down the probability of a rate hike this year.

The prevailing sentiment is that the Fed will maintain its current stance next month, directing attention to the meetings in November and December as investors eagerly await those decisions. The Fed's commitment to data-driven decision-making in shaping its monetary policy trajectory remains evident.

?

The question of whether the Federal Reserve will proceed with interest rate hikes or opt for a different course will loom over the markets, prompting investors to scrutinize every piece of economic data and adjust their projections accordingly. In essence, be prepared for a volatile ride.

European markets are poised for a positive opening, as the pan-European STOXX 600 S SXXP reaches a two-week peak. Inflation reports from Germany and Spain scheduled later in the day will offer additional insights into price dynamics within the region, setting the stage for the euro zone's inflation report on Thursday

Traders have adjusted their expectations, now favoring a 25-basis-point European Central Bank rate hike in September. This slight shift follows a more pronounced-than-expected contraction in euro zone business activity that led to a temporary pause prediction.

?

Across Asia, the dollar DXY exhibited minimal movement against a basket of currencies, following a significant overnight decline due to declining Treasury yields. Australia experienced a slowdown in inflation, hitting a 17-month low in July, suggesting that the need for further interest rate hikes might be mitigated. As a result, the Aussie AUDUSD dipped by 0.17%.

On Tuesday, the Biden administration disclosed a list of ten prescription medicines that will undergo their inaugural price negotiations via the US Medicare health program. Notably, drugs from Bristol Myers Squibb BMY , Novo Nordisk NOVO_B , and Pfizer PFE are among those slated for negotiation. The limited market response overnight suggests investors are adopting a cautious stance.

Lastly, for enthusiasts of chocolate, unfortunate news continues to surface. London cocoa futures on ICE have persistently reached new 46-year highs since late June. Challenges in West Africa's crops have led to dwindling supplies, contributing to a significant global deficit projected for the ongoing 2022/23 crop season.

In order not to miss similar news, you can subscribe to the newsletter now.